Impact & Causes of Urinary Stone: A Review

Authors

  • Rajesh Asija Maharshi Arvind Institute of Pharmacy, Jaipur, Rajasthan India
  • Amandeep Swami Maharshi Arvind Institute of Pharmacy, Jaipur, Rajasthan India
  • Kanha Ram Sharma Maharshi Arvind Institute of Pharmacy, Jaipur, Rajasthan India

DOI:

https://doi.org/10.61280/tjpls.v10i6.150

Keywords:

Urethra, Struvite, Calcium Oxalate, Urate, Silicate, Cystine

Abstract

The process of stone formation in the kidneys, bladder and/or urethra (urinary tract) is called urolithiasis. Men are twice as likely to produce stones as women. Stone obstruction of  the ureters or renal pelvis is characterized by excruciating, intermittent pain radiating from the flank to the groin or  genital area and the inner thigh. Rock types are named according to their mineral composition. The most common minerals are struvite (magnesium ammonium phosphate), calcium oxalate, urate, cystine and silica. The most abundant rock on Earth contains calcium. Protection measures depend on the type of stone.

Downloads

Download data is not yet available.

Author Biographies

Rajesh Asija, Maharshi Arvind Institute of Pharmacy, Jaipur, Rajasthan India

Principal & Professor

Amandeep Swami, Maharshi Arvind Institute of Pharmacy, Jaipur, Rajasthan India

Associate Professor

Kanha Ram Sharma, Maharshi Arvind Institute of Pharmacy, Jaipur, Rajasthan India

PG Scholar

References

Soundararajan P, Mahesh R, Ramesh T, Hazeena Begum V. Prevention of chronic calcium oxalate urolithiasis in patients with Aerva Lanata. Indian Journal of Experimental Biology, 44, 2006, 981-986.

Rana Gopal Singh, Sanjeev Kumar Behura, Rakesh Kumar. Litholytic properties of Kulattha (Dolichous Biflorus) versus potassium citrate in kidney stone disease: a comparative study. JAPI, 58, 2010, 287.

Kalpana Devi V, Baskar R, Varalakshmi P. Biochemical effects in normal and rock-fed mice treated with ripe banana (Musa Paradisiaca) seed juice. Ancient Life Sciences, 3 & 4, 1993, 451 – 461.

Bahuguna YM, Rawat MSM, Juya V, Gnanarajan G. Antilytic effects of Eleusine Coracana granules. Saudi Arabian Journal of Pharmaceutical Sciences, 17, 2009, 182.

Surendra K. Pareta, Kartik Chandra Patra, Ranjit Havansh. Inhibition of calcium oxalate crystallization by Achyranthes bidentata in vitro. Hydroalcoholic Extract: A way to prevent stones. International Journal of Pharmacy and Biological Sciences, 432.

Kalpana Devi V, Baskar R, Varalakshmi P. Biochemical effects of treatment with ripe juice of plantain (Musa Paradisiaca) in normal rats and stone-forming rats. Ancient Life Sciences, 3 and 4, 1993, 451 – 461.

Türk, C. (Chairman), T. K. c. (2011). Recipe for urinary stones. Updated March 2011, 1-103.

Riley Jr. RF, Çekim 13: Pop Kuresi, s. 14. 192–207 Riley, Jr. . Thiab Perazzella (2005)

9 Coy, Florida; Evan , A ; Worcester , E ( 2005 ). Clinical Nephrolithiasis Umut, B; Longman , CB ( 2003 ). “United States Study of Diagnosis, Treatment, and Outcomes of Primary Hyperoxaluria.” Pediatric Nephrology 18(10): 986–91. Research 115(10): 2598- 2608

Umut, B; Longman, C. B. (2003). “United States Study of Diagnosis, Treatment, and Outcomes of Primary Hyperoxaluria.” Pediatric Nephrology 18(10): 986–91.

National Endocrine and Metabolic Disease Information Service (2006). “Hyperparathyroidism (NIH Publication No. 6-3425).”

National Endocrine and Metabolic Disease Information Service (2008). “Renal tubular acidosis (NIH Publication No. 09–4696)”

Demes, Daniel. ASCP Rapid Compendium of Clinical Pathology, 2nd ed. ASCP Press, Chicago, 2009.

Clinical pathology of ethylene glycol poisoning. Archived from the original on 2 May 2012. Access date: 2012-05

Carl A. Osborne, D.P. (n.d.). University of Minnesota Minnesota Urolithiasis Center. Monitor CaOx to prevent uroliths, 1-2.

Weiss, M.; Liapis, H; Tomaszewski, J.E.; Arend, L. J. (2007). "Chapter 22: Pyelonephritis and related diseases, reflux nephropathy, hydronephrosis and nephrolithiasis." Janet in JC; Olson, J.L.; Schwartz, M. M. et al. Heptinstall

Demes, Daniel. ASCP Rapid Compendium of Clinical Pathology, 2nd ed. ASCP Press, Chicago, 2009.

Mo, O.W. (2006). "Kidney stones: pathophysiology and clinical management." Lancet 367(9507): 333–44.

Chory, N; Cooper B, Robertson W, Choong S, Rickards D, Unwin R (2010). "The Least Practical Guide to Kidney Stone Management". Nephron Clin Appl 116(3):c159–71

Reilly Jr. RF, Tshooj 13: Public Environment, p. 107-1 192–207, Reilly Jr. Thiab Perazella (2005)

Demes, Daniel. ASCP Rapid Compendium of Clinical Pathology, 2nd ed. ASCP Press, Chicago, 2009.

Eric Fjerstedt; Hanevik Lotta; Jepsen Jan-Olov; Hans-Goran Tiselius; Peter Soderqvist; Toth Dondenenberg (2003). "Urinary excretion of total cystine and the diamines arginine, lysine, and ornithine is associated with genetic findings in cystinuria patients treated with sulfhydryl compounds." Urology Research 31(6):417–25.

Osborne CA: Analysis of 451,891 canine uroliths, feline uroliths, and feline urethral plugs, 1981-2007: Minnesota Urolithiasis Center Report: VCNA 2008; 391: 83.

Knight J, Assimos DG, Easter L, Holmes RP (2010). "Fructose is metabolized into oxalic acid and glycolic acid."

Suman Kumar Mekap, Satyaranjan Mishra, Sabuj Sahoo and Prasana Kumar Panda. Anti-urolytic activity of Crataeva magna Lour. tough. Indian Journal of Natural Products and Resources, 1(2), 2011, 28-33.

Dietary Committee Reference Intakes for Vitamin D and Calcium, Tolerable Upper Intake Levels: Calcium and Vitamin D, p. 403-56 Committee to Review Dietary Reference Intakes for Vitamin D and Calcium (2011)

National Academies Committee on Fluoride in Drinking Water (2006). "Chapter 9: Effects on the Kidneys". Fluoride in Drinking Water: A Scientific Review of EPA Standards. Washington, DC: National Academies Press. 236-48: I.

Goodwin, J.S.; Mangum, M. R. (1998). “Challenging Quackery: Attitudes Toward Micronutrient Supplements in American Academic Medicine.” Archives of Internal Medicine 158(20): 2187–91. doi:10.1001/archinte.158.20.2187.

Rodman, J.S.; Seidman, C. (1996). "Chapter 8: Eating Problems". Rodman, J.S.; Seidman, C.; Jones, R. No More Kidney Stones (1st ed.). New York: John Wiley & Sons, Inc. s. 100-1 100–1 46–57. ISBN 978-0-471-12587-7.

Brawer, MK; Makarov, DV; Partin, AW; Roehrborn, CG; Nickel, JC; Lu, SH; Yoshimura, N; Chancellor, MB et al. (2008). "Best of the 2008 AUA Annual Meeting: Highlights from the 2008 Annual Meeting of the American Urological Association, May 17–22, 2008, Orlando, FL". Reviews in Urology 10 (2): 136–56. PMC 2483319. PMID 18660856.

Reilly Jr. RF, Chapter 13: Kidney stones, p. 192-207, Reilly Jr. and Perazella (2005)

Umut, B; Longman, C. B. (2003). “United States Study of Diagnosis, Treatment, and Outcomes of Primary Hyperoxaluria.” Service of Pediatr Nephrology 18(10): 986–91. Access date: 27 July 2011.

National Kidney and Urological Diseases Clearinghouse (2008). “Medullary sponge kidney (NIH publication number 08-6235).” Kidney and urinary tract diseases: List of topics and names from A to Z. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Public Health Service, US Department of Health and Human Services. Tau txais Lub Xya Hli 27, 2011.

Published

10-12-2023

How to Cite

Rajesh Asija, Amandeep Swami, and Kanha Ram Sharma. “Impact & Causes of Urinary Stone: A Review”. Tropical Journal of Pharmaceutical and Life Sciences, vol. 10, no. 6, Dec. 2023, pp. 80-86, doi:10.61280/tjpls.v10i6.150.
Statistics
152 Views | Downloads

Issue

Section

Review Article